BIIB Earnings Biogen
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q3 2026 | 2026-09-30 | -0.14 | 2026-10-28 | 10-Q |
| Q2 2026 | 2026-06-30 | 0.66 | 2026-07-29 | 10-Q |
| Q1 2026 | 2026-03-31 | 2.15 | 2026-04-29 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -0.35 | 2026-02-06 | 10-K |
| FY 2025 | 2025-12-31 | 8.79 | 2026-02-06 | 10-K |
| Q3 2025 | 2025-09-30 | 3.17 | 2025-10-30 | 10-Q |
| Q2 2025 | 2025-06-30 | 4.33 | 2025-07-31 | 10-Q |
| Q1 2025 | 2025-03-31 | 1.64 | 2025-05-01 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 1.82 | 2025-02-12 | 10-K |
| FY 2024 | 2024-12-31 | 11.18 | 2025-02-12 | 10-K |
| Q3 2024 | 2024-09-30 | 2.66 | 2024-10-30 | 10-Q |
| Q2 2024 | 2024-06-30 | 4.00 | 2024-08-01 | 10-Q |
| Q1 2024 | 2024-03-31 | 2.70 | 2024-04-24 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 1.70 | 2024-02-14 | 10-K |
| FY 2023 | 2023-12-31 | 7.97 | 2024-02-14 | 10-K |
| Q3 2023 | 2023-09-30 | -0.47 | 2023-11-08 | 10-Q |
| Q2 2023 | 2023-06-30 | 4.07 | 2023-07-25 | 10-Q |
| Q1 2023 | 2023-03-31 | 2.67 | 2023-04-25 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 3.73 | 2023-02-15 | 10-K |
| FY 2022 | 2022-12-31 | 20.87 | 2023-02-15 | 10-K |
| Q3 2022 | 2022-09-30 | 7.84 | 2022-10-25 | 10-Q |
| Q1 2022 | 2022-06-30 | 7.24 | 2022-07-20 | 10-Q |
| Q1 2022 | 2022-03-31 | 2.06 | 2022-05-03 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | 2.50 | 2022-02-03 | 10-K |
| FY 2021 | 2021-12-31 | 10.40 | 2022-02-03 | 10-K |
| Q3 2021 | 2021-09-30 | 2.22 | 2021-10-20 | 10-Q |
| Q2 2021 | 2021-06-30 | 2.99 | 2021-07-22 | 10-Q |
| Q1 2021 | 2021-03-31 | 2.69 | 2021-04-22 | 10-Q |
| Q4 2020 | 2020-12-31 | 2.32 | 2021-02-03 | 10-K |
| FY 2020 | 2020-12-31 | 24.80 | 2021-02-03 | 10-K |
| Q3 2020 | 2020-09-30 | 4.46 | 2020-10-21 | 10-Q |
| Q2 2020 | 2020-06-30 | 9.59 | 2020-07-22 | 10-Q |
| Q1 2020 | 2020-03-31 | 8.08 | 2020-04-23 | 10-Q |
| Q4 2019 | 2019-12-31 | 8.08 | 2020-02-06 | 10-K |
| FY 2019 | 2019-12-31 | 31.42 | 2020-02-06 | 10-K |
| Q3 2019 | 2019-09-30 | 8.39 | 2019-10-22 | 10-Q |
| Q2 2019 | 2019-06-30 | 7.85 | 2019-07-24 | 10-Q |
| Q1 2019 | 2019-03-31 | 7.15 | 2019-04-24 | 10-Q |
| Q4 2018 | 2018-12-31 | 4.73 | 2019-02-06 | 10-K |
| FY 2018 | 2018-12-31 | 21.58 | 2019-02-06 | 10-K |
| Q3 2018 | 2018-09-30 | 7.15 | 2018-10-23 | 10-Q |
| Q2 2018 | 2018-06-30 | 4.18 | 2018-07-24 | 10-Q |
| Q1 2018 | 2018-03-31 | 5.54 | 2018-04-24 | 10-Q |
| Q4 2017 | 2017-12-31 | -1.40 | 2018-02-01 | 10-K |
| FY 2017 | 2017-12-31 | 11.92 | 2018-02-01 | 10-K |
| Q3 2017 | 2017-09-30 | 5.79 | 2017-10-24 | 10-Q |
| Q2 2017 | 2017-06-30 | 4.07 | 2017-07-25 | 10-Q |
| Q1 2017 | 2017-03-31 | 3.46 | 2017-04-25 | 10-Q |
| Q4 2016 | 2016-12-31 | 2.99 | 2017-02-02 | 10-K |
| FY 2016 | 2016-12-31 | 16.93 | 2017-02-02 | 10-K |
| Q3 2016 | 2016-09-30 | 4.71 | 2016-10-26 | 10-Q |
| Q2 2016 | 2016-06-30 | 4.79 | 2016-07-21 | 10-Q |
| Q1 2016 | 2016-03-31 | 4.43 | 2016-04-21 | 10-Q |
| Q4 2015 | 2015-12-31 | 3.77 | 2016-02-03 | 10-K |
| FY 2015 | 2015-12-31 | 15.34 | 2016-02-03 | 10-K |
| Q3 2015 | 2015-09-30 | 4.15 | 2015-10-21 | 10-Q |
| Q2 2015 | 2015-06-30 | 3.93 | 2015-07-24 | 10-Q |
| Q1 2015 | 2015-03-31 | 3.49 | 2015-04-24 | 10-Q |
| Q4 2014 | 2014-12-31 | 3.74 | 2015-02-04 | 10-K |
| FY 2014 | 2014-12-31 | 12.37 | 2015-02-04 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.